期刊文献+

三维结构金纳米花的快速可控合成及其分析应用研究 被引量:2

Fast and Controllable Synthesis of Three-dimensional Gold-nanoflowers and Their Analytical Applications
下载PDF
导出
摘要 以多巴胺(DA)为还原剂和包被剂,与氯金酸(HAuCl4)作用,一步合成得到具有高度复杂三维结构的金纳米花(AuNFs)。合成方法简单、可控、操作性强,只需70℃水浴反应10 min。实验发现,多巴胺溶液的新鲜程度和浓度是决定AuNFs形貌的关键因素,而4-(2-羟乙基)-1-哌嗪乙烷磺酸(HEPES)可用于调节AuNFs的尺寸,引入常用表面活性剂如Triton X-100、Tween-80、CTAB等会影响其形貌。由于AuNFs具有复杂的三维结构,在棱角处可能存在强电场,在催化、光热治疗等方面有较广阔的应用前景。 A simple,controllable and feasible method to prepare gold nanoflowers(AuNFs) with a highly complex three-dimensional structure was developed by using dopamine(DA) as reducing agent and capping agent to react with gold chloride acid(HAuCl4) in 70 ℃ within 10 min.It was found that the freshness and concentration of dopamine solution were the key factors in controlling the morphology of AuNFs,while the concentration of 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid(HEPES) could be used to adjust the size of AuNFs,and the introduction of the common surfactants such as Triton X-100,Tween-80,CTAB could also affect the morphology of AuNFs.Because of the complex three-dimensional structure,AuNFs may have strong electric field at edges and corners,which makes AuNFs have potential applications in catalysis,photothermal therapy.
出处 《分析测试学报》 CAS CSCD 北大核心 2012年第9期1058-1063,共6页 Journal of Instrumental Analysis
基金 科技部重大新药创制科技重大专项(2010ZX09401-306-1-4) 重庆市科委攻关项目(CSTC.2010AA2015)
关键词 多巴胺 金纳米花 形貌 dopamine gold nanoflowers(AuNFs) morphology
  • 相关文献

参考文献18

  • 1Frens G. Nat. Phys. Sci. , 1973, 241 : 20 -22.
  • 2Sau T K, Murphy C J. J. Am. Chem. Soc., 2004, 126(28) : 8648 -8649.
  • 3Nikoobakht B, E1 -Sayed M A. Chem: Mater. , 2003, 15(10) : 1957 - 1962.
  • 4MurphyCJ, SanT K, Cole A M, OrendorffC J, GaoJ X, Gou L, HunyadiS E, Li T. J. Phys. Chem. B, 2005, 109(29) : 13857 - 13870.
  • 5Jana N R. Small, 2005, 1 (8/9) : 875 - 882.
  • 6Jana N R, Gearheart L, Murphy C J. Adv. Mater. , 2001, 13(18) : 1389 -1393.
  • 7Zhang L, Huang C Z, Li Y F, Li Q. Cryst. Growth Des. , 2009, 9(7) : 3211 -3217.
  • 8YangB, LuN, QiD, MaR, WuQ, HaoJ, LiuX, MuY, ReboudV, Kehagias N, Torres C M S, Boey FY C, ChenX, ChiL. Small, 2010, 6(9): 1038-1043.
  • 9Bums R S, LeWitt P A, Ebert M H. N. Engl. J. Med. , 1985, 312:1418 - 1421.
  • 10Baron R, Zayats M, Willner I. Anal. Chem. , 21105, 77(6) : 1566 -1571.

同被引文献18

  • 1Daniel M C, Astruc D. Chemical Reviews - Columbus, 2004, 104( 1 ) : 293 -346.
  • 2XiaYN, XiaXH, WangY, XieSF. MRS Bull., 2013, 38(4): 335 -344.
  • 3Murphy C J, Sau T K, Gole A M, Orendorff C J, Gao J, Gou L, Hunyadi SE, Li T. J. Phys. Chem. B, 2005, 109: 13857 - 13870.
  • 4Kim J H, Kang T, Yoo S M, Lee S Y, Kim B, Choi Y K. Nanotechnology, 2009, 20:235302 -235308.
  • 5Winkler K, Kaminska A, Wojciechowski T, Holyst R, Fialkowski M. Plasmonics, 2011, 6:697 -704.
  • 6Boca S, Rugina D, Pintea A, Barbu -Tudoran L, Astilean S. Nanotechnology, 2011, 22:055702 -055709.
  • 7Jena B K, Raj C R. Langmuir, 2007, 23:4064 -4070.
  • 8Alexeyeva N, Kozlova J, Sammelselg V, Ritslaid P, Mandar H, Tammeveski K. Appl. Su Sci., 2010, 256:3040-3046.
  • 9Wang L D, Zhang T, Zhang X Y, Li R Z, Zhu S Q, Wang L N. Nanosci. Nanotechnol. Lett. , 2013, 5 : 257 - 260.
  • 10Malyi O, Rabkin E. Acta Mater., 2012, 60:261-268.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部